Rapid RNA Vaccine Development


Research Institution

Imperial College London


Professor Robin Shattock and his team in Imperial College London’s Department of Infectious Disease developed a candidate vaccine within 14 days of getting the sequence from China. They have been testing the vaccine on animals since 10 February and plan to move to clinical trials in the summer. The self-amplifying RNA vaccine works by effectively injecting new genetic code into a muscle, instructing it to make a protein found on the surface of coronavirus, which triggers a protective immune response. Professor Robin Shattock told The Telegraph: "We have the kind of technology to be able to generate a vaccine with a speed that's never been realised before. Most vaccines are five years in the discovery phase, and at least one or two years to manufacture and get into trials."

Research Team

Robin Shattock
Head of Mucosal Infection and Immunity
Imperial College London

Project Details

Funding Sources

Project Phases

Planned Time to Trials

< 6 Months

Additional Resources


Hover for more information.
No items found.

Get In Touch

Directly connect with the responsible researchers by sending a message.
Thank you! Your message has been received and will be forwarded to the research team!
Oops! Something went wrong while submitting the form.